Quantification of Total and Mutant Huntingtin Protein Levels in Biospecimens Using a Novel alphaLISA Assay

The neurodegenerative Huntington’s disease (HD) is caused by a polyglutamine (polyQ) amplification in the huntingtin protein (HTT). Currently there is no effective therapy available for HD; however, several efforts are directed to develop and optimize HTT-lowering methods to improve HD phenotypes. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldo, Barbara, Sajjad, Muhammad Umar, Cheong, Rachel Y., Bigarreau, Julie, Vijayvargia, Ravi, McLean, Catriona, Perrier, Anselme L., Seong, Ihn Sik, Halliday, Glenda, Petersén, Åsa, Kirik, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2018
Materias:
Methods/New Tools
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179573/
https://www.ncbi.nlm.nih.gov/pubmed/30310861
http://dx.doi.org/10.1523/ENEURO.0234-18.2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179573/
https://www.ncbi.nlm.nih.gov/pubmed/30310861
http://dx.doi.org/10.1523/ENEURO.0234-18.2018

Ejemplares similares